体外循环心脏手术限制性与自由性氧疗的随机对照试验
单中心、患者与评估者盲法随机试验纳入1389例体外循环下冠脉搭桥和/或主动脉瓣置换成人,比较体外循环期间及脱机后1小时FiO2 50%与100%对临床结局的影响。中位随访5.9年,两组主要复合终点发生率均为24%,无显著差异,不良事件率亦无差异。
要点
- 体外循环期间及脱机后1小时FiO2 50%与100%在死亡、卒中、透析依赖肾衰或心衰复合终点上无差异。
- 限制性氧疗组体外循环期间中位PaO2为19-23 kPa,自由性组>60 kPa。
- 两组不良事件发生率无差异,支持限制性氧疗的安全性。
核心结论
- 在体外循环下冠脉搭桥和/或主动脉瓣置换成人中,限制性氧疗(FiO2 50%)与自由性氧疗(FiO2 100%)在死亡、透析依赖肾衰、卒中或新发/加重心衰方面无显著差异。
研究设计与样本
- 单中心、患者与评估者盲法随机对照试验,纳入1389例体外循环下冠脉搭桥和/或主动脉瓣置换成人,1:1随机分配至限制性(FiO2=50%)或自由性(FiO2=100%)氧疗,干预覆盖体外循环期间及脱机后1小时。
主要发现
- 限制性氧疗组体外循环期间中位PaO2为19-23 kPa,自由性氧疗组>60 kPa。
- 中位随访5.9年(IQR 2.5-8.3),限制性组167/695(24%)与自由性组168/694(24%)达到主要复合终点(HR 1.01,95%CI 0.8-1.3;P=0.92)。
- 两组不良事件发生率无差异。
关键数值与推荐
- 限制性氧疗策略:体外循环期间及脱机后1小时FiO2=50%。
- 自由性氧疗策略:体外循环期间及脱机后1小时FiO2=100%。
- 主要复合终点:随访期间死亡、卒中、需透析的肾衰竭或新发/加重心衰的时间。
临床怎么用
- 对于择期或急诊体外循环下冠脉搭桥和/或主动脉瓣置换成人,可考虑采用FiO2 50%的限制性氧疗策略,未增加主要不良结局风险。
局限性
- 单中心设计可能限制外推性。
- 仅纳入冠脉搭桥和/或主动脉瓣置换患者,其他心脏手术人群结果未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maintaining adequate oxygen delivery during cardiopulmonary bypass (CPB)-assisted cardiac surgery is crucial, but hyperoxia has been suggested to cause organ injury. We compared the effects of restrictive vs liberal oxygenation during CPB and weaning from CPB on clinical outcomes in cardiac surgery. METHODS: We conducted a single-centre, patient- and assessor-blinded randomised trial on adults undergoing CPB-assisted coronary artery bypass grafting, aortic valve replacement, or both. Participants were randomly assigned (1:1) to restrictive (Fio2=50%) or liberal (Fio2=100%) oxygen therapy during and for the first hour after weaning from CPB. The primary composite outcome was the time to death, stroke, renal failure requiring dialysis, or new-onset or worsening heart failure during follow-up. RESULTS: Among 1389 participants (mean age, 67 yr [range, 29-85 yr]; 17% female), randomisation to receive Fio2 50% resulted in median Pao2 levels of 19-23 kPa during CPB, compared with >60 kPa in participants receiving Fio2 100%. During a median follow-up period of 5.9 yr (interquartile range, 2.5-8.3), 167/695 (24%) participants in the restrictive oxygenation group and 168/694 (24%) participants in the liberal oxygenation group met the primary endpoint (hazard ratio, 1.01 [95% confidence interval, 0.8-1.3]; P=0.92). There was no difference in adverse event rates between restrictive and liberal oxygen therapy. CONCLUSIONS: Among patients undergoing elective or urgent CPB-assisted coronary artery bypass grafting, aortic valve replacement, or both, no significant differences were observed in mortality, dialysis-dependent renal failure, stroke, or new-onset or worsening heart failure between a restrictive oxygenation strategy (Fio2 50%) and a liberal oxygenation strategy (Fio2 100%) during CPB and the subsequent weaning period. CLINICAL TRIAL REGISTRATION: NCT02673931.
引用
- Wiberg S, Møller CH, Kjaergaard J, et al. Restrictive versus liberal oxygenation in patients undergoing cardiopulmonary bypass-assisted heart surgery: a randomised controlled trial. Br J Anaesth. 2025. PMID: 40975689. doi:10.1016/j.bja.2025.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。